SCHEMBL8905435

SCHEMBL8905435

CCOC(=O)[C@H](C[C@H](CC)Cc1ccc(C(C)(C)C)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
CTSS P25774 6/20 0.43
CTSK P43235 5/20 0.43
REN P00797 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.42
CTSL P07711 1/20 0.42
CTSB P07858 1/20 0.42
PPARG P37231 2/20 0.41
PPARA Q07869 2/20 0.41
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8905431 1.00 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19HTTALDH1A1
SCHEMBL5312993 0.88 CTSS (0.50) CYP1A2CYP2C9CYP2C19HTTALDH1A1
SCHEMBL8905018 0.86 REN (0.44) CYP1A2CYP2C9CYP2C19HTTALDH1A1
SCHEMBL8905013 0.86 REN (0.44) CYP1A2CYP2C9CYP2C19HTTALDH1A1
SCHEMBL8905705 0.81 CTSK (0.44) CTSSCTSKRENCTSLCTSB
SCHEMBL8905697 0.81 CTSK (0.44) CTSSCTSKRENCTSLCTSB
SCHEMBL20045974 0.81 PPARG (0.53) CYP1A2CYP2C9CYP2C19HTTALDH1A1
SCHEMBL14803767 0.81 PPARG (0.53) CYP1A2CYP2C9CYP2C19HTTALDH1A1
SCHEMBL8906223 0.79 MAPT (0.50) CYP1A2CYP2C9CYP2C19HTTALDH1A1
SCHEMBL8906225 0.79 MAPT (0.50) CYP1A2CYP2C9CYP2C19HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US claimed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP claimed
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed